Expression of human FUS protein in Drosophila leads to progressive neurodegeneration

Abstract

Mutations in the Fused in sarcoma/Translated in liposarcoma gene (FUS/TLS, FUS) have been identified among patients with amyotrophic lateral sclerosis (ALS). FUS protein aggregation is a major pathological hallmark of FUS proteinopathy, a group of neurodegenerative diseases characterized by FUS-immunoreactive inclusion bodies. We prepared transgenic Drosophila expressing either the wild type (Wt) or ALS-mutant human FUS protein (hFUS) using the UAS-Gal4 system. When expressing Wt, R524S or P525L mutant FUS in photoreceptors, mushroom bodies (MBs) or motor neurons (MNs), transgenic flies show age-dependent progressive neural damages, including axonal loss in MB neurons, morphological changes and functional impairment in MNs. The transgenic flies expressing the hFUS gene recapitulate key features of FUS proteinopathy, representing the first stable animal model for this group of devastating diseases.

Keywords

frontotemporal lobar degeneration (FTLD) / FUS proteinopathy / animal model / amyotrophic lateral sclerosis / neurodegeneration

References

[1] Aman, P., Panagopoulos, I., Lassen, C., Fioretos, T., Mencinger, M., Toresson, H., H?glund, M., Forster, A., Rabbitts, T.H., Ron, D., (1996). Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 37, 1-8 .8921363
[2] Bachmann, A., Kobler, O., Kittel, R.J., Wichmann, C., Sierralta, J., Sigrist, S.J., Gundelfinger, E.D., Knust, E., and Thomas, U. (2010). A perisynaptic ménage à trois between Dlg, DLin-7, and Metro controls proper organization of Drosophila synaptic junctions. J Neurosci 30, 5811-5824 .20427642
[3] Baechtold, H., Kuroda, M., Sok, J., Ron, D., Lopez, B.S., and Akhmedov, A.T. (1999). Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J Biol Chem 274, 34337-34342 .10567410
[4] B?umer, D., Hilton, D., Paine, S.M., Turner, M.R., Lowe, J., Talbot, K., and Ansorge, O. (2010). Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 75, 611-618 .20668261
[5] Belly, A., Moreau-Gachelin, F., Sadoul, R., and Goldberg, Y. (2005). Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads. Neurosci Lett 379, 152-157 .15843054
[6] Blijham, P.J., Schelhaas, H.J., Ter Laak, H.J., van Engelen, B.G., and Zwarts, M.J. (2007). Early diagnosis of ALS: the search for signs of denervation in clinically normal muscles. J Neurol Sci 263, 154-157 .17655869
[7] Brand, A.H., and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415 .8223268
[8] Chiò, A., Restagno, G., Brunetti, M., Ossola, I., Calvo, A., Mora, G., Sabatelli, M., Monsurrò, M.R., Battistini, S., Mandrioli, J., , and the ITALSGEN Consortium. (2009). Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol Aging 30, 1272-1275 .19450904
[9] Crozat, A., Aman, P., Mandahl, N., and Ron, D. (1993). Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644 .8510758
[10] Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M.E., Mackenzie, I.R., Capell, A., Schmid, B., (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29, 2841-2857 .20606625
[11] Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachibana, T., Nishikawa, T., Hicks, G.G., and Takumi, T. (2005). The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 15, 587-593 .15797031
[12] Fujita, Y., Fujita, S., Takatama, M., Ikeda, M., and Okamoto, K. (2010). Numerous FUS-positive inclusions in an elderly woman with motor neuron disease. Neuropathology 31, 170–176 .
[13] Hicks, G.G., Singh, N., Nashabi, A., Mai, S., Bozek, G., Klewes, L., Arapovic, D., White, E.K., Koury, M.J., Oltz, E.M., (2000). Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 24, 175-179 .10655065
[14] Huang, E.J., Zhang, J., Geser, F., Trojanowski, J.Q., Strober, J.B., Dickson, D.W., Brown, R.H. Jr, Shapiro, B.E., and Lomen-Hoerth, C. (2010). Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol 20, 1069-1076 .20579074
[15] Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H., and Suzuki, N. (2010). Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol 69, 152–162 .
[16] Johansen, J., Halpern, M.E., Johansen, K.M., and Keshishian, H. (1989). Stereotypic morphology of glutamatergic synapses on identified muscle cells of Drosophila larvae. J Neurosci 9, 710-725 .2563766
[17] Jokic, N., Gonzalez de Aguilar, J.L., Dimou, L., Lin, S., Fergani, A., Ruegg, M.A., Schwab, M.E., Dupuis, L., and Loeffler, J.P. (2006). The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep 7, 1162-1167 .17039253
[18] Kramer, J.M., and Staveley, B.E. (2003). GAL4 causes developmental defects and apoptosis when expressed in the developing eye of Drosophila melanogaster. Genet Mol Res 2, 43-47 .12917801
[19] Kwiatkowski, T.J. Jr, Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T., (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208 .19251627
[20] Lanson, N.A. Jr, Maltare, A., King, H., Smith, R., Kim, J.H., Taylor, J.P., Lloyd, T.E.Pandey, U.B. (2011). A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum Mol Genet 20 , 2510–2523 .20133767
[21] Li, Y., Ray, P., Rao, E.J., Shi, C., Guo, W., Chen, X., Woodruff, E.A. 3rd, Fushimi, K., and Wu, J.Y. (2010). A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci U S A 107, 3169-3174 .20133767
[22] Mackenzie, I.R., Munoz, D.G., Kusaka, H., Yokota, O., Ishihara, K., Roeber, S., Kretzschmar, H.A., Cairns, N.J., and Neumann, M. (2010). Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol 121, 207–218 .
[23] Munoz, D.G., Neumann, M., Kusaka, H., Yokota, O., Ishihara, K., Terada, S., Kuroda, S., and Mackenzie, I.R. (2009). FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118, 617-627 .19830439
[24] Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H.A., and Mackenzie, I.R. (2009). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922-2931 .19674978
[25] Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133 .17023659
[26] Okamoto, K., Hirai, S., Shoji, M., Senoh, Y., and Yamazaki, T. (1990). Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis. Acta Neuropathol 80, 222-226 .2202191
[27] Prasad, D.D., Ouchida, M., Lee, L., Rao, V.N., and Reddy, E.S. (1994). TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9, 3717-3729 .7970732
[28] Rabbitts, T.H., Forster, A., Larson, R., and Nathan, P. (1993). Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4, 175-180 .7503811
[29] Rezával, C., Werbajh, S., and Ceriani, M.F. (2007). Neuronal death in Drosophila triggered by GAL4 accumulation. Eur J Neurosci 25, 683-694 .17313569
[30] Sasaki, S., and Maruyama, S. (1994). Decreased synaptophysin immunoreactivity of the anterior horns in motor neuron disease. Acta Neuropathol 87, 125-128 .8171961
[31] Stewart, B.A., Schuster, C.M., Goodman, C.S., and Atwood, H.L. (1996). Homeostasis of synaptic transmission in Drosophila with genetically altered nerve terminal morphology. J Neurosci 16, 3877-3886 .8656281
[32] Syriani, E., Morales, M., and Gamez, J. (2010). FUS/TLS gene mutations are the second most frequent cause of familial ALS in the Spanish population. Amyotroph Lateral Scler 12, 118–123 .
[33] Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211 .19251628
[34] Yang, L., Embree, L.J., Tsai, S., and Hickstein, D.D. (1998). Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 273, 27761-27764 .9774382
[35] Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D. (1997). TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 110, 1741-1750 .9264461